id,title,publish_time,close_time,resolution,question_id,t,x
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 06:22:50.647617102,0.46
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 09:11:22.641156197,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 18:21:12.166475058,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 22:14:43.426279306,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 08:24:04.688767672,0.74
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 08:24:09.692112207,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-09 06:17:58.908295631,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 12:40:48.915427923,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-19 12:44:11.252731085,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 06:22:50.647617102,0.46
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 09:11:22.641156197,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 18:21:12.166475058,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 22:14:43.426279306,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 08:24:04.688767672,0.74
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 08:24:09.692112207,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-09 06:17:58.908295631,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 12:40:48.915427923,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-19 12:44:11.252731085,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 06:22:50.647617102,0.46
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 09:11:22.641156197,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 18:21:12.166475058,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 22:14:43.426279306,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 08:24:04.688767672,0.74
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 08:24:09.692112207,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-09 06:17:58.908295631,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 12:40:48.915427923,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-19 12:44:11.252731085,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 06:22:50.647617102,0.46
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 09:11:22.641156197,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 18:21:12.166475058,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 22:14:43.426279306,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 08:24:04.688767672,0.74
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 08:24:09.692112207,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-09 06:17:58.908295631,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 12:40:48.915427923,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-19 12:44:11.252731085,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 06:22:50.647617102,0.46
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 09:11:22.641156197,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 18:21:12.166475058,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 22:14:43.426279306,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 08:24:04.688767672,0.74
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 08:24:09.692112207,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-09 06:17:58.908295631,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 12:40:48.915427923,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-19 12:44:11.252731085,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 06:22:50.647617102,0.46
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 09:11:22.641156197,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 18:21:12.166475058,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 22:14:43.426279306,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 08:24:04.688767672,0.74
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 08:24:09.692112207,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-09 06:17:58.908295631,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 12:40:48.915427923,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-19 12:44:11.252731085,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-24 23:05:07.902913570,0.71
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 21:03:38.290427685,0.46
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-19 21:48:21.064096689,0.69
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-22 23:18:24.746838331,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-24 23:05:07.902913570,0.71
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 21:03:38.290427685,0.46
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-19 21:48:21.064096689,0.69
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-22 23:18:24.746838331,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-24 23:05:07.902913570,0.71
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 21:03:38.290427685,0.46
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-19 21:48:21.064096689,0.69
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-22 23:18:24.746838331,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-24 23:05:07.902913570,0.71
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 21:03:38.290427685,0.46
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-19 21:48:21.064096689,0.69
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-22 23:18:24.746838331,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 17:50:09.835129738,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 16:36:10.066504717,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:05:20.351460695,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:05:38.857068062,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-28 15:50:28.068683863,0.58
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 20:14:13.665875912,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 20:14:23.412652731,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 23:54:46.577861786,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 17:50:09.835129738,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 16:36:10.066504717,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:05:20.351460695,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:05:38.857068062,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-28 15:50:28.068683863,0.58
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 20:14:13.665875912,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 20:14:23.412652731,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 23:54:46.577861786,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 17:50:09.835129738,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 16:36:10.066504717,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:05:20.351460695,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:05:38.857068062,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-28 15:50:28.068683863,0.58
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 20:14:13.665875912,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 20:14:23.412652731,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 23:54:46.577861786,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 17:50:09.835129738,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 16:36:10.066504717,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:05:20.351460695,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:05:38.857068062,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-28 15:50:28.068683863,0.58
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 20:14:13.665875912,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 20:14:23.412652731,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 23:54:46.577861786,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 17:50:09.835129738,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 16:36:10.066504717,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:05:20.351460695,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:05:38.857068062,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-28 15:50:28.068683863,0.58
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 20:14:13.665875912,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 20:14:23.412652731,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 23:54:46.577861786,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 17:50:09.835129738,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 16:36:10.066504717,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:05:20.351460695,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:05:38.857068062,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-28 15:50:28.068683863,0.58
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 20:14:13.665875912,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 20:14:23.412652731,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 23:54:46.577861786,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-27 17:01:02.256794929,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-27 17:01:02.256794929,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-27 17:01:02.256794929,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-27 17:01:02.256794929,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-27 17:01:02.256794929,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 21:15:05.940672159,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 01:15:52.711176872,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 21:15:05.940672159,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 01:15:52.711176872,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 21:15:05.940672159,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 01:15:52.711176872,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 21:15:05.940672159,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 01:15:52.711176872,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 21:15:05.940672159,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 01:15:52.711176872,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 21:15:05.940672159,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 01:15:52.711176872,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 21:15:05.940672159,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 01:15:52.711176872,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 05:58:06.863696098,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:04:29.237933636,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 05:58:06.863696098,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:04:29.237933636,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 05:58:06.863696098,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:04:29.237933636,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 05:58:06.863696098,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:04:29.237933636,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 04:52:24.064115046,0.82
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 04:52:24.064115046,0.82
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 18:14:22.686008215,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:22:30.912770033,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 12:30:29.005059481,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:23:20.938390255,0.35
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:23:48.331603050,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 12:27:36.653010368,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 17:00:53.107265234,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 18:14:22.686008215,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:22:30.912770033,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 12:30:29.005059481,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:23:20.938390255,0.35
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:23:48.331603050,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 12:27:36.653010368,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 17:00:53.107265234,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 18:14:22.686008215,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:22:30.912770033,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 12:30:29.005059481,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:23:20.938390255,0.35
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:23:48.331603050,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 12:27:36.653010368,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 17:00:53.107265234,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 18:14:22.686008215,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:22:30.912770033,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 12:30:29.005059481,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:23:20.938390255,0.35
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:23:48.331603050,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 12:27:36.653010368,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 17:00:53.107265234,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 18:14:22.686008215,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:22:30.912770033,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 12:30:29.005059481,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:23:20.938390255,0.35
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:23:48.331603050,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 12:27:36.653010368,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 17:00:53.107265234,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 19:55:21.703220844,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-12 20:42:04.808569670,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-07 20:06:38.990064144,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 19:55:21.703220844,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-12 20:42:04.808569670,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-07 20:06:38.990064144,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 20:19:49.802659035,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 20:19:53.936122894,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-12 07:38:50.705762625,0.67
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-19 17:39:55.690963030,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 10:09:11.307929277,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 20:19:49.802659035,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 20:19:53.936122894,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-12 07:38:50.705762625,0.67
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-19 17:39:55.690963030,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 10:09:11.307929277,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 20:19:49.802659035,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 20:19:53.936122894,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-12 07:38:50.705762625,0.67
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-19 17:39:55.690963030,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 10:09:11.307929277,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 20:19:49.802659035,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 20:19:53.936122894,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-12 07:38:50.705762625,0.67
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-19 17:39:55.690963030,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 10:09:11.307929277,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 22:33:41.657419205,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 18:15:41.328769445,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 22:33:41.657419205,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 18:15:41.328769445,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 22:33:41.657419205,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 18:15:41.328769445,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 22:33:41.657419205,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 18:15:41.328769445,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 22:33:41.657419205,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 18:15:41.328769445,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 23:39:00.498675108,0.48
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 17:29:33.068301916,0.64
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 23:39:00.498675108,0.48
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 17:29:33.068301916,0.64
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 23:39:00.498675108,0.48
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 17:29:33.068301916,0.64
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 06:56:26.861697197,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 06:56:26.861697197,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 07:19:06.655203581,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 12:47:03.343416691,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 20:31:50.341805935,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 16:52:53.438581228,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 10:32:15.660975695,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 16:37:38.658667803,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 22:12:48.912685156,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 07:19:06.655203581,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 12:47:03.343416691,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 20:31:50.341805935,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 16:52:53.438581228,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 10:32:15.660975695,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 16:37:38.658667803,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 22:12:48.912685156,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 07:19:06.655203581,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 12:47:03.343416691,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 20:31:50.341805935,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 16:52:53.438581228,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 10:32:15.660975695,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 16:37:38.658667803,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 22:12:48.912685156,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 07:19:06.655203581,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 12:47:03.343416691,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 20:31:50.341805935,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 16:52:53.438581228,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 10:32:15.660975695,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 16:37:38.658667803,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 22:12:48.912685156,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 07:19:06.655203581,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 12:47:03.343416691,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 20:31:50.341805935,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 16:52:53.438581228,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 10:32:15.660975695,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 16:37:38.658667803,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 22:12:48.912685156,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 07:19:06.655203581,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 12:47:03.343416691,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 20:31:50.341805935,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 16:52:53.438581228,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 10:32:15.660975695,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 16:37:38.658667803,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 22:12:48.912685156,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-26 00:06:32.392956257,0.4
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 20:36:04.072292566,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-26 00:06:32.392956257,0.4
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 20:36:04.072292566,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 19:34:42.057831764,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-16 21:13:03.398502827,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 16:42:57.178760052,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 19:34:42.057831764,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-16 21:13:03.398502827,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 16:42:57.178760052,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-16 22:30:04.933052778,0.35
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-16 22:30:06.597131252,0.35
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-16 22:30:04.933052778,0.35
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-16 22:30:06.597131252,0.35
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 06:13:43.158726454,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 06:13:43.158726454,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 21:19:41.435964108,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 21:19:41.435964108,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 21:19:41.435964108,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 22:09:17.952010870,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 22:09:17.952010870,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 17:55:42.516839265,0.59
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 12:31:33.463311672,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-29 19:51:12.405250788,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 17:55:42.516839265,0.59
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 12:31:33.463311672,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-29 19:51:12.405250788,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 02:50:37.460077047,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 02:50:37.460077047,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 18:55:02.400897503,0.67
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 19:32:25.872150183,0.48
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 17:33:18.995943308,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 15:24:00.104268312,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 17:39:19.949039459,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-25 16:32:01.341360569,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-27 07:47:46.796947479,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 18:55:02.400897503,0.67
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 19:32:25.872150183,0.48
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 17:33:18.995943308,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 15:24:00.104268312,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 17:39:19.949039459,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-25 16:32:01.341360569,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-27 07:47:46.796947479,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 18:55:02.400897503,0.67
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 19:32:25.872150183,0.48
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 17:33:18.995943308,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 15:24:00.104268312,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 17:39:19.949039459,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-25 16:32:01.341360569,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-27 07:47:46.796947479,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 18:55:02.400897503,0.67
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 19:32:25.872150183,0.48
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 17:33:18.995943308,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 15:24:00.104268312,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 17:39:19.949039459,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-25 16:32:01.341360569,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-27 07:47:46.796947479,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 18:55:02.400897503,0.67
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 19:32:25.872150183,0.48
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 17:33:18.995943308,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 15:24:00.104268312,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 17:39:19.949039459,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-25 16:32:01.341360569,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-27 07:47:46.796947479,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 18:33:54.017323971,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:29:21.992361784,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 08:58:41.940546989,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-11 09:46:09.881277323,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 10:44:30.252430916,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 18:39:48.929220915,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-25 20:58:56.769862890,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:31:32.908123732,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:32:12.381763220,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 23:48:47.441425323,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 18:33:54.017323971,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:29:21.992361784,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 08:58:41.940546989,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-11 09:46:09.881277323,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 10:44:30.252430916,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 18:39:48.929220915,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-25 20:58:56.769862890,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:31:32.908123732,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:32:12.381763220,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 23:48:47.441425323,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 18:33:54.017323971,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:29:21.992361784,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 08:58:41.940546989,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-11 09:46:09.881277323,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 10:44:30.252430916,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 18:39:48.929220915,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-25 20:58:56.769862890,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:31:32.908123732,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:32:12.381763220,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 23:48:47.441425323,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 18:33:54.017323971,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:29:21.992361784,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 08:58:41.940546989,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-11 09:46:09.881277323,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 10:44:30.252430916,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 18:39:48.929220915,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-25 20:58:56.769862890,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:31:32.908123732,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:32:12.381763220,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 23:48:47.441425323,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 18:33:54.017323971,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:29:21.992361784,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 08:58:41.940546989,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-11 09:46:09.881277323,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 10:44:30.252430916,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 18:39:48.929220915,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-25 20:58:56.769862890,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:31:32.908123732,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:32:12.381763220,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 23:48:47.441425323,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 18:33:54.017323971,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:29:21.992361784,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 08:58:41.940546989,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-11 09:46:09.881277323,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 10:44:30.252430916,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 18:39:48.929220915,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-25 20:58:56.769862890,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:31:32.908123732,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:32:12.381763220,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 23:48:47.441425323,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 18:33:53.279027462,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 18:33:53.279027462,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 10:24:36.965466976,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 10:24:41.742828131,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 14:25:47.638464928,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 10:24:36.965466976,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 10:24:41.742828131,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 14:25:47.638464928,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 10:53:56.629996777,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 10:53:56.629996777,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 01:05:20.271213531,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 16:18:03.430509567,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 17:12:07.405557394,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 23:33:53.981982231,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 07:50:29.644027472,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-19 15:05:42.987912655,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 12:05:07.045663834,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 12:47:14.902650595,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 01:05:20.271213531,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 16:18:03.430509567,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 17:12:07.405557394,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 23:33:53.981982231,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 07:50:29.644027472,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-19 15:05:42.987912655,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 12:05:07.045663834,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 12:47:14.902650595,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 16:28:23.233195543,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-25 22:13:56.994252443,0.92
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 16:28:23.233195543,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-25 22:13:56.994252443,0.92
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 16:28:23.233195543,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-25 22:13:56.994252443,0.92
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 16:28:23.233195543,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-25 22:13:56.994252443,0.92
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 23:52:30.724956512,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 23:52:30.724956512,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 23:52:30.724956512,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 23:52:30.724956512,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 03:19:52.737112045,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-12 03:29:04.709215164,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 03:19:52.737112045,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-12 03:29:04.709215164,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 03:19:52.737112045,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-12 03:29:04.709215164,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 03:19:52.737112045,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-12 03:29:04.709215164,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-12 22:37:06.531897305,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-12 22:37:06.531897305,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-12 22:37:06.531897305,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-12 22:37:06.531897305,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-12 22:37:06.531897305,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 18:59:16.145081997,0.63
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-12 07:07:59.592908621,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 19:55:04.291131496,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 18:59:16.145081997,0.63
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-12 07:07:59.592908621,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 19:55:04.291131496,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 18:59:16.145081997,0.63
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-12 07:07:59.592908621,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 19:55:04.291131496,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 18:59:16.145081997,0.63
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-12 07:07:59.592908621,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 19:55:04.291131496,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 18:59:16.145081997,0.63
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-12 07:07:59.592908621,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 19:55:04.291131496,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-15 21:03:13.623371363,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 13:39:13.185333729,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 21:49:37.620528936,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-15 21:03:13.623371363,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 13:39:13.185333729,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 21:49:37.620528936,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-15 21:03:13.623371363,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 13:39:13.185333729,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 21:49:37.620528936,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-15 21:03:13.623371363,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 13:39:13.185333729,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 21:49:37.620528936,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-15 21:03:13.623371363,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 13:39:13.185333729,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 21:49:37.620528936,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-15 21:03:13.623371363,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 13:39:13.185333729,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 21:49:37.620528936,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-09 04:28:38.526111840,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-09 04:28:46.928219795,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-09 04:28:38.526111840,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-09 04:28:46.928219795,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-09 04:28:38.526111840,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-09 04:28:46.928219795,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-09 04:28:38.526111840,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-09 04:28:46.928219795,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-09 04:28:38.526111840,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-09 04:28:46.928219795,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-17 23:24:14.359127760,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 08:48:51.587232113,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-17 23:24:14.359127760,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 08:48:51.587232113,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-26 20:02:10.984074354,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-26 20:02:14.999753714,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-26 20:02:10.984074354,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-26 20:02:14.999753714,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-26 20:02:10.984074354,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-26 20:02:14.999753714,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-26 20:02:10.984074354,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-26 20:02:14.999753714,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-26 20:02:10.984074354,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-26 20:02:14.999753714,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-30 16:51:20.107347727,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 08:03:50.144701958,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-30 16:51:20.107347727,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 08:03:50.144701958,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-30 16:51:20.107347727,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 08:03:50.144701958,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-01 17:24:48.536803007,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-01 17:24:48.536803007,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-01 17:24:48.536803007,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-11 06:25:17.449779272,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-11 06:25:30.478212595,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-11 06:25:17.449779272,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-11 06:25:30.478212595,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-13 17:03:36.251328468,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-13 17:03:36.251328468,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-13 23:47:50.868031502,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-13 23:47:50.868031502,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-18 11:14:48.301043749,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-18 11:14:48.301043749,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 19:53:25.392114878,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 19:53:25.392114878,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 19:53:25.392114878,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 19:53:25.392114878,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-19 06:06:47.360528946,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-19 06:06:47.360528946,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-19 06:06:47.360528946,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-19 06:06:47.360528946,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-19 06:06:47.360528946,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-22 07:55:59.391741753,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-22 07:55:59.391741753,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:48:39.602900028,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:48:39.602900028,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:48:39.602900028,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:48:39.602900028,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:48:39.602900028,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:48:39.602900028,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-26 23:21:50.364470005,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-26 23:21:50.364470005,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-26 23:21:50.364470005,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-26 23:21:50.364470005,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-29 22:48:31.497849703,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-29 22:48:31.497849703,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-29 22:48:31.497849703,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 19:17:01.222886801,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 19:17:01.222886801,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 00:36:56.599897861,0.35
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 00:37:31.713194132,0.32
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-29 02:59:26.157592773,0.33
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 01:21:29.315263271,0.36
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 12:28:58.891253948,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 15:15:33.571439505,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 15:16:04.411539555,0.63
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-12 00:06:24.276597023,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 10:30:44.617309332,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 17:28:10.326667786,0.84
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 18:01:51.757985353,0.74
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 18:02:05.945721626,0.73
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 22:31:42.474664927,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 22:31:54.886250973,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:46:27.983898640,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:46:31.237912893,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:46:51.006988287,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 18:54:21.158977509,0.89
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 18:54:50.235063314,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 18:54:58.382105112,0.92
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 07:19:53.422262192,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-05 18:44:03.470158577,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-12 09:44:16.207634926,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-31 10:02:24.902441740,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 00:36:56.599897861,0.35
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 00:37:31.713194132,0.32
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-29 02:59:26.157592773,0.33
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 01:21:29.315263271,0.36
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 12:28:58.891253948,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 15:15:33.571439505,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 15:16:04.411539555,0.63
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-12 00:06:24.276597023,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 10:30:44.617309332,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 17:28:10.326667786,0.84
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 18:01:51.757985353,0.74
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 18:02:05.945721626,0.73
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 22:31:42.474664927,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 22:31:54.886250973,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:46:27.983898640,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:46:31.237912893,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:46:51.006988287,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 18:54:21.158977509,0.89
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 18:54:50.235063314,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 18:54:58.382105112,0.92
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 07:19:53.422262192,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-05 18:44:03.470158577,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-12 09:44:16.207634926,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-31 10:02:24.902441740,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 00:36:56.599897861,0.35
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 00:37:31.713194132,0.32
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-29 02:59:26.157592773,0.33
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 01:21:29.315263271,0.36
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 12:28:58.891253948,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 15:15:33.571439505,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 15:16:04.411539555,0.63
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-12 00:06:24.276597023,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 10:30:44.617309332,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 17:28:10.326667786,0.84
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 18:01:51.757985353,0.74
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 18:02:05.945721626,0.73
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 22:31:42.474664927,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 22:31:54.886250973,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:46:27.983898640,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:46:31.237912893,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:46:51.006988287,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 18:54:21.158977509,0.89
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 18:54:50.235063314,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 18:54:58.382105112,0.92
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 07:19:53.422262192,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-05 18:44:03.470158577,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-12 09:44:16.207634926,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-31 10:02:24.902441740,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 01:20:33.733083487,0.32
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 01:30:41.881196737,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 19:13:29.147556067,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 04:26:03.179843903,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 18:56:43.404728651,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 01:07:11.366956711,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 16:07:32.604391336,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-04 21:48:30.504819393,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 07:39:07.674030542,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-08 06:02:48.053105116,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-19 01:55:59.862940311,0.84
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 07:33:20.308309793,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:44:51.180199623,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 01:20:33.733083487,0.32
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 01:30:41.881196737,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 19:13:29.147556067,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 04:26:03.179843903,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 18:56:43.404728651,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 01:07:11.366956711,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 16:07:32.604391336,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-04 21:48:30.504819393,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 07:39:07.674030542,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-08 06:02:48.053105116,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-19 01:55:59.862940311,0.84
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 07:33:20.308309793,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:44:51.180199623,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 01:20:33.733083487,0.32
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 01:30:41.881196737,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 19:13:29.147556067,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 04:26:03.179843903,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 18:56:43.404728651,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 01:07:11.366956711,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 16:07:32.604391336,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-04 21:48:30.504819393,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 07:39:07.674030542,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-08 06:02:48.053105116,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-19 01:55:59.862940311,0.84
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 07:33:20.308309793,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:44:51.180199623,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 01:20:33.733083487,0.32
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 01:30:41.881196737,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 19:13:29.147556067,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 04:26:03.179843903,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 18:56:43.404728651,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 01:07:11.366956711,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 16:07:32.604391336,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-04 21:48:30.504819393,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 07:39:07.674030542,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-08 06:02:48.053105116,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-19 01:55:59.862940311,0.84
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 07:33:20.308309793,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:44:51.180199623,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 09:52:19.401765347,0.2
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 18:19:53.589977026,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 09:13:44.465748549,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:12:10.565115929,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 07:44:32.553659439,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-27 08:21:17.639415741,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 09:52:19.401765347,0.2
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 18:19:53.589977026,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 09:13:44.465748549,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:12:10.565115929,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 07:44:32.553659439,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-27 08:21:17.639415741,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 09:52:19.401765347,0.2
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 18:19:53.589977026,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 09:13:44.465748549,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:12:10.565115929,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 07:44:32.553659439,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-27 08:21:17.639415741,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 09:52:19.401765347,0.2
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 18:19:53.589977026,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 09:13:44.465748549,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:12:10.565115929,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 07:44:32.553659439,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-27 08:21:17.639415741,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 09:52:19.401765347,0.2
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 18:19:53.589977026,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 09:13:44.465748549,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:12:10.565115929,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 07:44:32.553659439,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-27 08:21:17.639415741,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 09:52:19.401765347,0.2
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 18:19:53.589977026,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 09:13:44.465748549,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:12:10.565115929,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 07:44:32.553659439,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-27 08:21:17.639415741,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 15:08:35.431155443,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 15:08:35.431155443,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 15:08:35.431155443,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 15:08:35.431155443,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 22:50:51.335626602,0.48
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 22:51:04.029847860,0.43
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 00:14:33.436746597,0.62
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 17:28:29.218087673,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:52:41.440718412,0.89
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:52:46.881762028,0.89
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 17:18:32.720659971,0.92
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 22:50:51.335626602,0.48
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 22:51:04.029847860,0.43
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 00:14:33.436746597,0.62
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 17:28:29.218087673,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:52:41.440718412,0.89
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:52:46.881762028,0.89
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 17:18:32.720659971,0.92
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 22:50:51.335626602,0.48
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 22:51:04.029847860,0.43
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 00:14:33.436746597,0.62
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 17:28:29.218087673,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:52:41.440718412,0.89
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:52:46.881762028,0.89
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 17:18:32.720659971,0.92
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 22:50:51.335626602,0.48
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 22:51:04.029847860,0.43
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 00:14:33.436746597,0.62
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 17:28:29.218087673,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:52:41.440718412,0.89
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:52:46.881762028,0.89
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 17:18:32.720659971,0.92
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 22:50:51.335626602,0.48
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 22:51:04.029847860,0.43
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 00:14:33.436746597,0.62
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 17:28:29.218087673,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:52:41.440718412,0.89
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:52:46.881762028,0.89
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 17:18:32.720659971,0.92
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 22:50:51.335626602,0.48
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-25 22:51:04.029847860,0.43
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 00:14:33.436746597,0.62
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 17:28:29.218087673,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:52:41.440718412,0.89
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:52:46.881762028,0.89
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 17:18:32.720659971,0.92
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 00:36:52.307101011,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 03:51:31.132784366,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 04:49:58.702613592,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 04:51:24.835306406,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 12:40:54.261767864,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 16:47:29.237507343,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-14 01:06:31.180262089,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-16 20:56:22.787956238,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 19:34:51.503475428,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 05:10:58.812132597,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 05:11:05.569007397,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 16:50:31.118508339,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 23:00:31.717625856,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 13:44:25.735743284,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 13:44:28.211941481,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 14:17:01.834184647,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 18:45:06.056670904,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 00:36:52.307101011,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 03:51:31.132784366,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 04:49:58.702613592,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 04:51:24.835306406,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 12:40:54.261767864,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 16:47:29.237507343,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-14 01:06:31.180262089,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-16 20:56:22.787956238,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 19:34:51.503475428,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 05:10:58.812132597,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 05:11:05.569007397,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 16:50:31.118508339,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 23:00:31.717625856,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 13:44:25.735743284,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 13:44:28.211941481,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 14:17:01.834184647,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 18:45:06.056670904,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 00:36:52.307101011,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 03:51:31.132784366,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 04:49:58.702613592,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 04:51:24.835306406,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 12:40:54.261767864,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 16:47:29.237507343,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-14 01:06:31.180262089,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-16 20:56:22.787956238,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 19:34:51.503475428,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 05:10:58.812132597,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 05:11:05.569007397,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 16:50:31.118508339,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 23:00:31.717625856,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 13:44:25.735743284,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 13:44:28.211941481,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 14:17:01.834184647,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 18:45:06.056670904,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 00:36:52.307101011,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 03:51:31.132784366,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 04:49:58.702613592,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 04:51:24.835306406,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 12:40:54.261767864,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 16:47:29.237507343,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-14 01:06:31.180262089,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-16 20:56:22.787956238,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 19:34:51.503475428,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 05:10:58.812132597,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 05:11:05.569007397,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 16:50:31.118508339,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 23:00:31.717625856,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 13:44:25.735743284,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 13:44:28.211941481,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 14:17:01.834184647,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 18:45:06.056670904,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 00:36:52.307101011,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 03:51:31.132784366,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 04:49:58.702613592,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 04:51:24.835306406,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 12:40:54.261767864,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 16:47:29.237507343,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-14 01:06:31.180262089,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-16 20:56:22.787956238,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 19:34:51.503475428,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 05:10:58.812132597,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 05:11:05.569007397,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 16:50:31.118508339,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 23:00:31.717625856,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 13:44:25.735743284,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 13:44:28.211941481,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 14:17:01.834184647,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 18:45:06.056670904,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 00:36:52.307101011,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 03:51:31.132784366,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 04:49:58.702613592,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 04:51:24.835306406,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 12:40:54.261767864,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 16:47:29.237507343,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-14 01:06:31.180262089,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-16 20:56:22.787956238,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 19:34:51.503475428,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 05:10:58.812132597,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 05:11:05.569007397,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 16:50:31.118508339,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 23:00:31.717625856,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 13:44:25.735743284,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 13:44:28.211941481,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 14:17:01.834184647,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 18:45:06.056670904,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 11:53:40.302505970,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 11:53:47.743087769,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 06:31:37.698672533,0.44
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 13:55:28.923269272,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:49:14.102767944,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 17:13:14.794274569,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:59:47.278078318,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:53:41.939641714,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 19:06:49.050340891,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:00:33.783538580,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:00:44.700146675,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 11:53:40.302505970,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 11:53:47.743087769,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 06:31:37.698672533,0.44
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 13:55:28.923269272,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:49:14.102767944,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 17:13:14.794274569,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:59:47.278078318,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:53:41.939641714,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 19:06:49.050340891,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:00:33.783538580,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:00:44.700146675,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 11:53:40.302505970,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 11:53:47.743087769,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 06:31:37.698672533,0.44
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 13:55:28.923269272,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:49:14.102767944,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 17:13:14.794274569,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:59:47.278078318,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:53:41.939641714,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 19:06:49.050340891,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:00:33.783538580,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:00:44.700146675,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 11:53:40.302505970,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 11:53:47.743087769,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 06:31:37.698672533,0.44
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 13:55:28.923269272,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:49:14.102767944,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 17:13:14.794274569,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:59:47.278078318,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:53:41.939641714,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 19:06:49.050340891,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:00:33.783538580,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:00:44.700146675,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 11:53:40.302505970,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 11:53:47.743087769,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 06:31:37.698672533,0.44
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 13:55:28.923269272,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:49:14.102767944,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 17:13:14.794274569,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 19:59:47.278078318,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:53:41.939641714,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 19:06:49.050340891,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:00:33.783538580,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 20:00:44.700146675,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 14:01:14.084131479,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 14:01:14.084131479,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 14:01:14.084131479,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-26 14:01:14.084131479,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-27 08:01:47.574836731,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 07:51:50.945607901,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 08:21:57.365257740,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 08:23:49.962275743,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-27 08:01:47.574836731,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 07:51:50.945607901,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 08:21:57.365257740,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 08:23:49.962275743,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-27 02:14:26.678519964,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-29 08:10:30.469616175,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 21:51:34.888926506,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 04:57:45.742738724,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 10:10:56.672926903,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:53:36.608226299,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-09 08:20:53.953119755,0.6993636363636362
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-12 00:11:29.409314156,0.7195318181818181
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 00:36:03.009747267,0.7578727272727271
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 04:57:04.014598131,0.6797181818181818
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 18:29:18.944042921,0.6263954545454545
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 20:13:30.564418554,0.6822136363636363
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 19:05:37.075012207,0.7195272727272727
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 18:40:18.218127251,0.7689045454545453
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 22:26:41.657244921,0.7926545454545454
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 18:49:18.967837811,0.8237727272727272
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 19:52:20.381577969,0.8518363636363635
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 20:12:57.516531944,0.8733363636363635
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-01 21:56:37.851444244,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-14 05:19:30.481313467,0.9514083497548471
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-01 04:13:32.579659224,0.928249998645931
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-12 19:01:20.930992842,0.9512251818338349
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-27 02:14:26.678519964,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-29 08:10:30.469616175,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 21:51:34.888926506,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 04:57:45.742738724,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 10:10:56.672926903,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:53:36.608226299,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-09 08:20:53.953119755,0.6993636363636362
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-12 00:11:29.409314156,0.7195318181818181
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 00:36:03.009747267,0.7578727272727271
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 04:57:04.014598131,0.6797181818181818
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 18:29:18.944042921,0.6263954545454545
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 20:13:30.564418554,0.6822136363636363
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 19:05:37.075012207,0.7195272727272727
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 18:40:18.218127251,0.7689045454545453
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 22:26:41.657244921,0.7926545454545454
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 18:49:18.967837811,0.8237727272727272
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 19:52:20.381577969,0.8518363636363635
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 20:12:57.516531944,0.8733363636363635
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-01 21:56:37.851444244,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-14 05:19:30.481313467,0.9514083497548471
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-01 04:13:32.579659224,0.928249998645931
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-12 19:01:20.930992842,0.9512251818338349
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-27 02:14:26.678519964,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-29 08:10:30.469616175,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 21:51:34.888926506,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 04:57:45.742738724,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 10:10:56.672926903,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:53:36.608226299,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-09 08:20:53.953119755,0.6993636363636362
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-12 00:11:29.409314156,0.7195318181818181
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 00:36:03.009747267,0.7578727272727271
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 04:57:04.014598131,0.6797181818181818
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 18:29:18.944042921,0.6263954545454545
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 20:13:30.564418554,0.6822136363636363
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 19:05:37.075012207,0.7195272727272727
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 18:40:18.218127251,0.7689045454545453
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 22:26:41.657244921,0.7926545454545454
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 18:49:18.967837811,0.8237727272727272
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 19:52:20.381577969,0.8518363636363635
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 20:12:57.516531944,0.8733363636363635
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-01 21:56:37.851444244,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-14 05:19:30.481313467,0.9514083497548471
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-01 04:13:32.579659224,0.928249998645931
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-12 19:01:20.930992842,0.9512251818338349
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-27 02:14:26.678519964,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-29 08:10:30.469616175,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 21:51:34.888926506,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 04:57:45.742738724,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 10:10:56.672926903,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:53:36.608226299,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-09 08:20:53.953119755,0.6993636363636362
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-12 00:11:29.409314156,0.7195318181818181
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 00:36:03.009747267,0.7578727272727271
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 04:57:04.014598131,0.6797181818181818
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 18:29:18.944042921,0.6263954545454545
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 20:13:30.564418554,0.6822136363636363
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 19:05:37.075012207,0.7195272727272727
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 18:40:18.218127251,0.7689045454545453
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 22:26:41.657244921,0.7926545454545454
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 18:49:18.967837811,0.8237727272727272
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 19:52:20.381577969,0.8518363636363635
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 20:12:57.516531944,0.8733363636363635
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-01 21:56:37.851444244,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-14 05:19:30.481313467,0.9514083497548471
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-01 04:13:32.579659224,0.928249998645931
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-12 19:01:20.930992842,0.9512251818338349
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-27 02:14:26.678519964,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-29 08:10:30.469616175,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 21:51:34.888926506,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 04:57:45.742738724,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 10:10:56.672926903,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:53:36.608226299,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-09 08:20:53.953119755,0.6993636363636362
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-12 00:11:29.409314156,0.7195318181818181
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 00:36:03.009747267,0.7578727272727271
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 04:57:04.014598131,0.6797181818181818
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 18:29:18.944042921,0.6263954545454545
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 20:13:30.564418554,0.6822136363636363
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 19:05:37.075012207,0.7195272727272727
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 18:40:18.218127251,0.7689045454545453
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 22:26:41.657244921,0.7926545454545454
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 18:49:18.967837811,0.8237727272727272
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 19:52:20.381577969,0.8518363636363635
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 20:12:57.516531944,0.8733363636363635
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-01 21:56:37.851444244,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-14 05:19:30.481313467,0.9514083497548471
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-01 04:13:32.579659224,0.928249998645931
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-12 19:01:20.930992842,0.9512251818338349
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-27 02:14:26.678519964,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-29 08:10:30.469616175,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 21:51:34.888926506,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-03 04:57:45.742738724,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 10:10:56.672926903,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 20:53:36.608226299,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-09 08:20:53.953119755,0.6993636363636362
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-12 00:11:29.409314156,0.7195318181818181
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 00:36:03.009747267,0.7578727272727271
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 04:57:04.014598131,0.6797181818181818
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 18:29:18.944042921,0.6263954545454545
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 20:13:30.564418554,0.6822136363636363
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 19:05:37.075012207,0.7195272727272727
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 18:40:18.218127251,0.7689045454545453
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 22:26:41.657244921,0.7926545454545454
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 18:49:18.967837811,0.8237727272727272
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 19:52:20.381577969,0.8518363636363635
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 20:12:57.516531944,0.8733363636363635
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-01 21:56:37.851444244,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-14 05:19:30.481313467,0.9514083497548471
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-01 04:13:32.579659224,0.928249998645931
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-12 19:01:20.930992842,0.9512251818338349
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-27 15:22:19.847883940,0.35
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-27 15:22:19.847883940,0.35
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-27 15:22:19.847883940,0.35
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 15:44:11.679631472,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 15:44:11.679631472,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 17:22:58.269938231,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 15:08:21.016015291,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 21:55:55.183040142,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 23:49:39.960855246,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 12:35:35.310279131,0.84
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-06 18:48:19.114472628,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 17:22:58.269938231,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 15:08:21.016015291,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 21:55:55.183040142,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 23:49:39.960855246,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 12:35:35.310279131,0.84
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-06 18:48:19.114472628,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 17:22:58.269938231,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 15:08:21.016015291,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 21:55:55.183040142,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 23:49:39.960855246,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 12:35:35.310279131,0.84
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-06 18:48:19.114472628,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 17:22:58.269938231,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 15:08:21.016015291,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 21:55:55.183040142,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 23:49:39.960855246,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 12:35:35.310279131,0.84
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-06 18:48:19.114472628,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 17:22:58.269938231,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 15:08:21.016015291,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 21:55:55.183040142,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 23:49:39.960855246,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 12:35:35.310279131,0.84
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-06 18:48:19.114472628,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 17:22:58.269938231,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 15:08:21.016015291,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 21:55:55.183040142,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 23:49:39.960855246,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 12:35:35.310279131,0.84
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-06 18:48:19.114472628,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 19:35:54.134820700,0.4
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 19:35:54.134820700,0.4
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-28 19:35:54.134820700,0.4
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-29 22:30:04.486672640,0.1
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-29 22:30:04.486672640,0.1
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 03:48:23.804297447,0.34
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 03:19:12.002225637,0.74
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 22:16:58.575746775,0.56
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 17:56:40.691182613,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 02:51:49.722553015,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 22:45:08.265787600,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 03:48:23.804297447,0.34
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 03:19:12.002225637,0.74
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 22:16:58.575746775,0.56
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 17:56:40.691182613,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 02:51:49.722553015,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 22:45:08.265787600,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 03:48:23.804297447,0.34
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 03:19:12.002225637,0.74
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 22:16:58.575746775,0.56
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 17:56:40.691182613,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 02:51:49.722553015,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 22:45:08.265787600,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 03:48:23.804297447,0.34
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 03:19:12.002225637,0.74
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 22:16:58.575746775,0.56
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 17:56:40.691182613,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 02:51:49.722553015,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 22:45:08.265787600,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 03:48:23.804297447,0.34
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 03:19:12.002225637,0.74
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 22:16:58.575746775,0.56
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 17:56:40.691182613,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 02:51:49.722553015,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 22:45:08.265787600,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 03:48:23.804297447,0.34
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 03:19:12.002225637,0.74
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 22:16:58.575746775,0.56
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 17:56:40.691182613,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 02:51:49.722553015,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 22:45:08.265787600,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 12:19:52.051476479,0.64
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 12:19:52.051476479,0.64
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 12:19:52.051476479,0.64
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 20:11:17.734991789,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 22:58:28.461996555,0.63
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 20:11:17.734991789,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 22:58:28.461996555,0.63
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-30 20:11:17.734991789,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 22:58:28.461996555,0.63
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-31 13:34:47.242741823,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-31 13:34:47.242741823,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-31 13:34:47.242741823,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-31 13:34:47.242741823,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-31 13:34:47.242741823,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-03-31 13:34:47.242741823,0.41
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-01 21:14:14.368646622,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-01 21:14:32.330367565,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 02:40:56.283807993,0.31
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:14:48.794011831,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:15:18.394686937,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:15:37.065514088,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-05 18:10:54.657326937,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-01 21:14:14.368646622,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-01 21:14:32.330367565,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 02:40:56.283807993,0.31
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:14:48.794011831,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:15:18.394686937,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:15:37.065514088,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-05 18:10:54.657326937,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-01 21:14:14.368646622,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-01 21:14:32.330367565,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 02:40:56.283807993,0.31
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:14:48.794011831,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:15:18.394686937,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:15:37.065514088,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-05 18:10:54.657326937,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-01 21:14:14.368646622,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-01 21:14:32.330367565,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 02:40:56.283807993,0.31
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:14:48.794011831,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:15:18.394686937,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:15:37.065514088,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-05 18:10:54.657326937,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-01 21:14:14.368646622,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-01 21:14:32.330367565,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 02:40:56.283807993,0.31
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:14:48.794011831,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:15:18.394686937,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:15:37.065514088,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-05 18:10:54.657326937,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-01 21:14:14.368646622,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-01 21:14:32.330367565,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 02:40:56.283807993,0.31
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:14:48.794011831,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:15:18.394686937,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:15:37.065514088,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-05 18:10:54.657326937,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-01 21:14:14.368646622,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-01 21:14:32.330367565,0.49
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 02:40:56.283807993,0.31
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:14:48.794011831,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:15:18.394686937,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 01:15:37.065514088,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-05 18:10:54.657326937,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 05:31:36.733202696,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 05:31:36.733202696,0.42
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 08:10:14.042981386,0.33
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 09:55:46.651262760,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 13:42:56.960627794,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 13:14:49.315922976,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 06:58:51.630138636,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 09:22:28.835027218,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 12:59:27.773342609,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 08:10:14.042981386,0.33
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 09:55:46.651262760,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 13:42:56.960627794,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 13:14:49.315922976,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 06:58:51.630138636,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 09:22:28.835027218,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 12:59:27.773342609,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 08:10:14.042981386,0.33
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 09:55:46.651262760,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 13:42:56.960627794,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 13:14:49.315922976,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 06:58:51.630138636,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 09:22:28.835027218,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 12:59:27.773342609,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 08:10:14.042981386,0.33
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 09:55:46.651262760,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 13:42:56.960627794,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 13:14:49.315922976,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 06:58:51.630138636,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 09:22:28.835027218,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 12:59:27.773342609,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 08:10:14.042981386,0.33
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 09:55:46.651262760,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 13:42:56.960627794,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 13:14:49.315922976,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 06:58:51.630138636,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 09:22:28.835027218,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 12:59:27.773342609,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 08:10:14.042981386,0.33
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 09:55:46.651262760,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 13:42:56.960627794,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 13:14:49.315922976,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 06:58:51.630138636,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 09:22:28.835027218,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 12:59:27.773342609,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 08:10:14.042981386,0.33
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 09:55:46.651262760,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 13:42:56.960627794,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 13:14:49.315922976,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 06:58:51.630138636,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 09:22:28.835027218,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 12:59:27.773342609,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 08:10:14.042981386,0.33
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 09:55:46.651262760,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 13:42:56.960627794,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 13:14:49.315922976,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 06:58:51.630138636,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 09:22:28.835027218,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 12:59:27.773342609,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 08:10:14.042981386,0.33
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 09:55:46.651262760,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 13:42:56.960627794,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 13:14:49.315922976,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 06:58:51.630138636,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 09:22:28.835027218,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 12:59:27.773342609,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 10:59:05.846724033,0.3
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 23:57:14.651211739,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 22:07:04.395591974,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 02:48:37.324967146,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 23:50:50.301853418,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-29 00:01:21.778533220,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-24 02:58:55.409877539,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 10:59:05.846724033,0.3
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 23:57:14.651211739,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 22:07:04.395591974,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 02:48:37.324967146,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 23:50:50.301853418,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-29 00:01:21.778533220,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-24 02:58:55.409877539,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 10:59:05.846724033,0.3
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 23:57:14.651211739,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 22:07:04.395591974,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 02:48:37.324967146,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 23:50:50.301853418,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-29 00:01:21.778533220,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-24 02:58:55.409877539,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 13:28:48.585998297,0.59
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 13:28:52.687554359,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 10:38:07.527188540,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:16:30.683864594,0.92
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 09:52:49.274149656,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 01:22:44.690748453,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-22 08:50:24.136677027,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-10 10:00:41.481702328,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 21:59:27.982021809,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-25 09:27:32.877755880,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 13:28:48.585998297,0.59
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 13:28:52.687554359,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 10:38:07.527188540,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:16:30.683864594,0.92
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 09:52:49.274149656,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 01:22:44.690748453,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-22 08:50:24.136677027,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-10 10:00:41.481702328,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 21:59:27.982021809,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-25 09:27:32.877755880,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 13:28:48.585998297,0.59
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 13:28:52.687554359,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 10:38:07.527188540,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:16:30.683864594,0.92
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 09:52:49.274149656,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 01:22:44.690748453,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-22 08:50:24.136677027,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-10 10:00:41.481702328,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 21:59:27.982021809,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-25 09:27:32.877755880,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 13:28:48.585998297,0.59
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 13:28:52.687554359,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 10:38:07.527188540,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:16:30.683864594,0.92
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 09:52:49.274149656,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 01:22:44.690748453,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-22 08:50:24.136677027,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-10 10:00:41.481702328,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 21:59:27.982021809,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-25 09:27:32.877755880,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 13:28:48.585998297,0.59
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 13:28:52.687554359,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 10:38:07.527188540,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:16:30.683864594,0.92
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 09:52:49.274149656,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 01:22:44.690748453,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-22 08:50:24.136677027,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-10 10:00:41.481702328,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 21:59:27.982021809,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-25 09:27:32.877755880,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 13:28:48.585998297,0.59
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 13:28:52.687554359,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 10:38:07.527188540,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:16:30.683864594,0.92
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 09:52:49.274149656,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 01:22:44.690748453,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-22 08:50:24.136677027,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-10 10:00:41.481702328,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 21:59:27.982021809,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-25 09:27:32.877755880,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 20:34:48.474014759,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 17:29:10.766973972,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-02 20:34:48.474014759,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 17:29:10.766973972,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 10:02:52.866118193,0.58
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-02 10:46:26.877531290,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 10:02:52.866118193,0.58
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-02 10:46:26.877531290,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 10:02:52.866118193,0.58
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-02 10:46:26.877531290,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 13:57:01.209980249,0.64
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 16:23:38.594131947,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 21:31:49.795438051,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 13:57:01.209980249,0.64
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 16:23:38.594131947,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 21:31:49.795438051,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 13:57:01.209980249,0.64
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 16:23:38.594131947,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 21:31:49.795438051,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 13:57:01.209980249,0.64
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 16:23:38.594131947,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 21:31:49.795438051,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 13:57:01.209980249,0.64
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 16:23:38.594131947,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 21:31:49.795438051,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 13:57:01.209980249,0.64
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 16:23:38.594131947,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 21:31:49.795438051,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 13:57:01.209980249,0.64
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 16:23:38.594131947,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 21:31:49.795438051,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 13:57:01.209980249,0.64
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 16:23:38.594131947,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 21:31:49.795438051,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 13:57:01.209980249,0.64
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 16:23:38.594131947,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 21:31:49.795438051,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 13:57:01.209980249,0.64
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 16:23:38.594131947,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 21:31:49.795438051,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 13:57:01.209980249,0.64
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 16:23:38.594131947,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 21:31:49.795438051,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 16:51:21.464407206,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 05:49:14.329550505,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 16:47:16.656326771,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-20 02:50:43.493624210,0.69
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 03:09:08.078327656,0.51
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 22:03:58.699958801,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 22:04:15.413251638,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-07 17:33:54.300689459,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-26 14:56:49.253579378,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 16:51:21.464407206,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 05:49:14.329550505,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 16:47:16.656326771,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-20 02:50:43.493624210,0.69
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 03:09:08.078327656,0.51
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 22:03:58.699958801,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 22:04:15.413251638,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-07 17:33:54.300689459,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-26 14:56:49.253579378,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 16:51:21.464407206,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 05:49:14.329550505,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 16:47:16.656326771,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-20 02:50:43.493624210,0.69
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 03:09:08.078327656,0.51
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 22:03:58.699958801,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 22:04:15.413251638,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-07 17:33:54.300689459,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-26 14:56:49.253579378,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 16:51:21.464407206,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 05:49:14.329550505,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 16:47:16.656326771,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-20 02:50:43.493624210,0.69
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 03:09:08.078327656,0.51
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 22:03:58.699958801,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 22:04:15.413251638,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-07 17:33:54.300689459,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-26 14:56:49.253579378,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 16:51:21.464407206,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 05:49:14.329550505,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 16:47:16.656326771,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-20 02:50:43.493624210,0.69
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 03:09:08.078327656,0.51
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 22:03:58.699958801,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 22:04:15.413251638,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-07 17:33:54.300689459,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-26 14:56:49.253579378,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 18:54:47.551064491,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 18:29:00.193681002,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 15:50:02.812919140,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 18:54:47.551064491,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 18:29:00.193681002,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 15:50:02.812919140,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 18:54:47.551064491,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 18:29:00.193681002,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 15:50:02.812919140,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 18:54:47.551064491,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 18:29:00.193681002,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 15:50:02.812919140,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 18:54:47.551064491,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 18:29:00.193681002,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 15:50:02.812919140,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 18:54:47.551064491,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 18:29:00.193681002,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 15:50:02.812919140,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 18:54:47.551064491,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 18:29:00.193681002,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 15:50:02.812919140,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 23:26:59.089287758,0.68
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 23:27:29.824362040,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 07:56:31.030591011,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 18:07:10.511258125,0.69
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 17:30:21.125637770,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 17:31:09.627462149,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 17:31:27.841561794,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-28 18:24:43.911826849,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-28 18:25:04.197160721,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-06 08:07:44.536397456,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-06 08:08:25.398355484,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 23:26:59.089287758,0.68
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 23:27:29.824362040,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 07:56:31.030591011,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 18:07:10.511258125,0.69
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 17:30:21.125637770,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 17:31:09.627462149,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 17:31:27.841561794,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-28 18:24:43.911826849,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-28 18:25:04.197160721,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-06 08:07:44.536397456,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-06 08:08:25.398355484,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 23:26:59.089287758,0.68
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 23:27:29.824362040,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 07:56:31.030591011,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 18:07:10.511258125,0.69
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 17:30:21.125637770,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 17:31:09.627462149,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 17:31:27.841561794,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-28 18:24:43.911826849,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-28 18:25:04.197160721,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-06 08:07:44.536397456,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-06 08:08:25.398355484,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 23:26:59.089287758,0.68
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-05 23:27:29.824362040,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 07:56:31.030591011,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 18:07:10.511258125,0.69
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 17:30:21.125637770,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 17:31:09.627462149,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 17:31:27.841561794,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-28 18:24:43.911826849,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-28 18:25:04.197160721,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-06 08:07:44.536397456,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-06 08:08:25.398355484,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 01:27:22.741101742,0.63
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 01:27:22.741101742,0.63
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 01:27:22.741101742,0.63
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 01:27:22.741101742,0.63
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 01:27:22.741101742,0.63
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 03:36:47.992763281,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 03:36:47.992763281,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 03:36:47.992763281,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 03:36:47.992763281,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 03:36:47.992763281,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 06:03:20.609347582,0.67
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-11 01:31:22.991439819,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 04:45:49.980853081,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 08:45:18.183428288,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 21:13:20.605555058,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 14:34:51.509320974,0.51
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:03:32.009760141,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 08:38:31.467228651,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 05:25:35.006852865,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-08 00:30:00.688616514,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-12 18:33:47.523810863,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-01 15:08:40.597633123,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 06:03:20.609347582,0.67
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-11 01:31:22.991439819,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 04:45:49.980853081,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 08:45:18.183428288,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 21:13:20.605555058,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-27 14:34:51.509320974,0.51
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:03:32.009760141,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 08:38:31.467228651,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 05:25:35.006852865,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-08 00:30:00.688616514,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-12 18:33:47.523810863,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-01 15:08:40.597633123,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 13:51:46.052890539,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 14:23:06.357961416,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 14:23:17.865880489,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 21:07:22.039116383,0.57
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 15:06:50.887191296,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:16:58.372546673,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 13:49:10.587034225,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-12 18:20:29.421907663,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 13:51:46.052890539,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 14:23:06.357961416,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 14:23:17.865880489,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 21:07:22.039116383,0.57
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 15:06:50.887191296,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:16:58.372546673,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 13:49:10.587034225,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-12 18:20:29.421907663,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 13:51:46.052890539,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 14:23:06.357961416,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 14:23:17.865880489,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 21:07:22.039116383,0.57
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 15:06:50.887191296,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:16:58.372546673,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 13:49:10.587034225,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-12 18:20:29.421907663,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 13:51:46.052890539,0.75
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 14:23:06.357961416,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 14:23:17.865880489,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 21:07:22.039116383,0.57
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 15:06:50.887191296,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:16:58.372546673,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 13:49:10.587034225,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-12 18:20:29.421907663,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 16:44:20.737511635,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:24:56.866204262,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 15:33:49.645604610,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 00:47:18.681766033,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 15:25:05.743666649,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-28 14:15:01.316017628,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 16:44:20.737511635,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:24:56.866204262,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 15:33:49.645604610,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 00:47:18.681766033,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 15:25:05.743666649,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-28 14:15:01.316017628,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 16:44:20.737511635,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:24:56.866204262,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 15:33:49.645604610,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 00:47:18.681766033,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 15:25:05.743666649,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-28 14:15:01.316017628,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 16:44:20.737511635,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:24:56.866204262,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 15:33:49.645604610,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 00:47:18.681766033,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 15:25:05.743666649,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-28 14:15:01.316017628,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 16:44:20.737511635,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:24:56.866204262,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 15:33:49.645604610,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 00:47:18.681766033,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 15:25:05.743666649,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-28 14:15:01.316017628,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 16:44:20.737511635,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 00:24:56.866204262,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 15:33:49.645604610,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 00:47:18.681766033,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 15:25:05.743666649,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-28 14:15:01.316017628,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 16:44:37.226298332,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 20:04:07.747520447,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-06 16:44:37.226298332,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 20:04:07.747520447,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 16:25:08.967845201,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 22:30:50.483835220,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 16:25:08.967845201,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 22:30:50.483835220,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 16:25:08.967845201,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 22:30:50.483835220,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 16:25:08.967845201,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 22:30:50.483835220,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-07 16:25:08.967845201,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 22:30:50.483835220,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-08 16:00:48.429237604,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 12:55:04.933242083,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-08 16:00:48.429237604,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 12:55:04.933242083,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-08 16:00:48.429237604,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 12:55:04.933242083,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-08 16:00:48.429237604,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 12:55:04.933242083,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-08 16:00:48.429237604,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-20 12:55:04.933242083,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 02:32:53.643383026,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 02:33:02.004567146,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:37:43.717870951,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 02:32:53.643383026,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 02:33:02.004567146,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:37:43.717870951,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 02:32:53.643383026,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 02:33:02.004567146,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:37:43.717870951,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 02:32:53.643383026,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 02:33:02.004567146,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:37:43.717870951,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 02:32:53.643383026,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 02:33:02.004567146,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:37:43.717870951,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 17:54:51.003449440,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 12:38:44.805974007,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 00:28:17.930309296,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-10 17:54:51.003449440,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 12:38:44.805974007,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 00:28:17.930309296,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-13 18:14:40.884199858,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 00:47:51.080212116,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 22:03:31.136366844,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 14:35:18.462846994,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 14:43:09.599887609,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 14:43:34.547239542,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 12:13:14.407137632,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-13 18:14:40.884199858,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 00:47:51.080212116,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 22:03:31.136366844,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 14:35:18.462846994,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 14:43:09.599887609,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 14:43:34.547239542,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 12:13:14.407137632,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-13 18:14:40.884199858,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 00:47:51.080212116,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 22:03:31.136366844,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 14:35:18.462846994,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 14:43:09.599887609,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 14:43:34.547239542,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 12:13:14.407137632,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-15 13:40:06.554377317,0.2
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-15 13:40:06.554377317,0.2
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 20:46:37.992195129,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 18:13:31.936103344,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:07:30.985894680,0.71
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-26 14:36:41.366000414,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 20:46:37.992195129,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 18:13:31.936103344,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:07:30.985894680,0.71
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-26 14:36:41.366000414,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 21:22:53.540232420,0.79
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 21:22:53.540232420,0.79
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 21:41:57.062908887,0.58
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-11 14:23:24.639870405,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:49:12.649770021,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 21:41:57.062908887,0.58
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-11 14:23:24.639870405,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:49:12.649770021,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 21:41:57.062908887,0.58
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-11 14:23:24.639870405,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:49:12.649770021,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 23:00:35.960965157,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-13 18:08:50.520784855,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-17 23:00:35.960965157,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-13 18:08:50.520784855,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 06:53:30.666399240,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 06:59:13.895811081,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 07:03:39.246989965,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 07:04:01.850282669,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 17:05:59.370362997,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 17:14:24.369707346,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 17:20:34.846154928,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-20 02:47:17.316922426,0.84
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-20 02:56:28.332166433,0.84
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 03:46:17.485882998,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 02:59:06.077204943,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 23:14:52.519798756,0.53
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 00:09:55.129006386,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 20:32:48.364464045,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 03:42:38.492377520,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 15:42:58.858831644,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 05:04:30.720010042,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-27 02:55:07.402860880,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 06:53:30.666399240,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 06:59:13.895811081,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 07:03:39.246989965,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 07:04:01.850282669,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 17:05:59.370362997,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 17:14:24.369707346,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 17:20:34.846154928,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-20 02:47:17.316922426,0.84
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-20 02:56:28.332166433,0.84
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 03:46:17.485882998,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 02:59:06.077204943,0.5
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 23:14:52.519798756,0.53
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 00:09:55.129006386,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 20:32:48.364464045,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 03:42:38.492377520,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 15:42:58.858831644,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 05:04:30.720010042,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-27 02:55:07.402860880,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 10:36:06.549180269,0.79
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 10:36:06.549180269,0.79
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 10:36:06.549180269,0.79
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 12:14:43.670487642,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-08 18:21:47.267320632,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 12:14:43.670487642,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-08 18:21:47.267320632,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 15:39:23.299988270,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-25 16:37:58.638441801,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 15:39:23.299988270,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-25 16:37:58.638441801,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 15:39:23.299988270,0.76
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-25 16:37:58.638441801,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 17:56:37.759197712,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-25 04:04:35.278560162,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 13:35:17.344864607,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 15:07:30.469495535,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 03:48:57.932459116,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 21:29:27.159563541,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-08 04:38:14.247168303,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 17:56:37.759197712,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-25 04:04:35.278560162,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 13:35:17.344864607,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 15:07:30.469495535,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 03:48:57.932459116,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 21:29:27.159563541,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-08 04:38:14.247168303,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 17:56:37.759197712,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-25 04:04:35.278560162,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 13:35:17.344864607,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 15:07:30.469495535,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 03:48:57.932459116,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 21:29:27.159563541,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-08 04:38:14.247168303,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 17:56:37.759197712,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-25 04:04:35.278560162,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 13:35:17.344864607,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 15:07:30.469495535,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 03:48:57.932459116,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 21:29:27.159563541,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-08 04:38:14.247168303,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 17:56:37.759197712,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-25 04:04:35.278560162,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 13:35:17.344864607,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 15:07:30.469495535,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 03:48:57.932459116,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 21:29:27.159563541,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-08 04:38:14.247168303,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 17:56:37.759197712,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-25 04:04:35.278560162,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 13:35:17.344864607,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 15:07:30.469495535,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 03:48:57.932459116,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 21:29:27.159563541,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-08 04:38:14.247168303,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-18 17:56:37.759197712,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-25 04:04:35.278560162,0.77
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 13:35:17.344864607,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 15:07:30.469495535,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 03:48:57.932459116,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 21:29:27.159563541,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-08 04:38:14.247168303,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 14:08:33.650685787,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-04 14:46:47.720700502,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 14:08:33.650685787,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-04 14:46:47.720700502,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-22 14:08:33.650685787,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-04 14:46:47.720700502,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 17:04:34.680675507,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 17:04:34.680675507,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 21:29:40.459760189,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 21:29:40.459760189,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 21:29:40.459760189,0.25
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 23:56:12.799815655,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:08:12.198438644,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-23 23:56:12.799815655,0.45
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:08:12.198438644,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 01:26:40.652167082,0.48
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 23:03:13.651214361,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 01:26:40.652167082,0.48
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 23:03:13.651214361,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 01:26:40.652167082,0.48
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 23:03:13.651214361,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-24 01:26:40.652167082,0.48
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 23:03:13.651214361,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-25 23:20:57.092456102,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-25 23:20:57.092456102,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-25 23:20:57.092456102,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-25 23:20:57.092456102,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-25 23:20:57.092456102,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-28 00:13:06.558189392,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-28 00:13:19.508882999,0.53
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 23:13:43.027301311,0.69
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 23:38:04.183535337,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-28 00:13:06.558189392,0.61
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-28 00:13:19.508882999,0.53
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 23:13:43.027301311,0.69
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 23:38:04.183535337,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-28 14:53:38.561670542,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-28 14:53:38.561670542,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 18:11:40.864186287,0.59
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 18:11:54.723162651,0.62
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 01:10:51.360751867,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-04 00:06:37.716708422,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-04 00:06:43.480372190,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 18:11:40.864186287,0.59
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 18:11:54.723162651,0.62
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 01:10:51.360751867,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-04 00:06:37.716708422,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-04 00:06:43.480372190,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 18:11:40.864186287,0.59
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 18:11:54.723162651,0.62
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 01:10:51.360751867,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-04 00:06:37.716708422,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-04 00:06:43.480372190,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 18:11:40.864186287,0.59
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 18:11:54.723162651,0.62
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 01:10:51.360751867,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-04 00:06:37.716708422,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-04 00:06:43.480372190,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 18:11:40.864186287,0.59
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 18:11:54.723162651,0.62
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 01:10:51.360751867,0.6
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-04 00:06:37.716708422,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-04 00:06:43.480372190,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:45:27.328018904,0.35
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 08:11:55.550448418,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-29 21:45:27.328018904,0.35
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 08:11:55.550448418,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 04:06:42.107042789,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 04:06:43.475698709,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 03:29:00.649136305,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 20:02:40.904929638,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 04:06:42.107042789,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 04:06:43.475698709,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 03:29:00.649136305,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 20:02:40.904929638,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 04:06:42.107042789,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 04:06:43.475698709,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 03:29:00.649136305,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 20:02:40.904929638,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 04:06:42.107042789,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-04-30 04:06:43.475698709,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 03:29:00.649136305,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 20:02:40.904929638,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 21:50:52.063953876,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 21:51:30.058478594,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 21:51:33.358506680,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 20:18:40.470121384,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 19:43:09.485277891,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 21:50:52.063953876,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 21:51:30.058478594,0.86
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-01 21:51:33.358506680,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-04 20:18:40.470121384,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 19:43:09.485277891,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:21:23.027290106,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:21:23.027290106,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:21:23.027290106,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:21:23.027290106,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-02 16:21:23.027290106,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 00:24:54.984272242,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 00:24:57.866172075,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 00:24:54.984272242,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 00:24:57.866172075,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 00:24:54.984272242,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 00:24:57.866172075,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 00:24:54.984272242,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-03 00:24:57.866172075,0.87
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 06:10:25.821920156,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 12:46:29.783040047,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 06:10:25.821920156,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 12:46:29.783040047,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-05 06:10:25.821920156,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 12:46:29.783040047,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-06 07:10:22.141571760,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-05 04:02:46.521048307,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 01:15:20.747401476,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-06 07:10:22.141571760,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-05 04:02:46.521048307,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 01:15:20.747401476,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-06 07:10:22.141571760,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-05 04:02:46.521048307,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 01:15:20.747401476,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-06 07:10:22.141571760,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-05 04:02:46.521048307,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 01:15:20.747401476,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-06 07:10:22.141571760,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-05 04:02:46.521048307,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 01:15:20.747401476,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-06 07:10:22.141571760,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-05 04:02:46.521048307,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 01:15:20.747401476,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-06 07:10:22.141571760,0.91
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-05 04:02:46.521048307,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 01:15:20.747401476,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-09 23:50:27.199716091,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-06 16:41:10.723080397,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-09 23:50:27.199716091,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-06 16:41:10.723080397,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 05:52:13.629570007,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 05:52:13.629570007,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 05:52:13.629570007,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 05:52:13.629570007,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 05:52:13.629570007,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 05:52:13.629570007,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 05:52:13.629570007,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 10:00:55.581391335,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 10:02:45.860030651,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 10:00:55.581391335,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 10:02:45.860030651,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 10:00:55.581391335,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 10:02:45.860030651,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 17:54:52.183222294,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-10 17:54:52.183222294,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-17 07:23:17.976625681,0.01
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-17 07:23:17.976625681,0.01
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-17 07:23:17.976625681,0.01
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 01:11:21.598788023,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 01:11:21.598788023,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 01:11:21.598788023,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 01:11:21.598788023,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 01:11:21.598788023,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 22:20:43.216034889,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 22:20:43.216034889,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 22:20:43.216034889,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 23:36:13.692600489,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 23:36:16.496493101,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 07:45:37.664939404,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 23:36:13.692600489,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 23:36:16.496493101,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 07:45:37.664939404,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 23:36:13.692600489,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-18 23:36:16.496493101,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 07:45:37.664939404,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 16:54:19.592477798,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-27 02:24:50.010656834,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-08 01:15:46.747334480,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-07 04:26:48.896189451,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-07 04:26:51.699409246,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 00:17:31.002094030,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-22 04:32:16.475910187,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 16:54:19.592477798,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-27 02:24:50.010656834,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-08 01:15:46.747334480,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-07 04:26:48.896189451,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-07 04:26:51.699409246,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 00:17:31.002094030,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-22 04:32:16.475910187,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 16:54:19.592477798,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-27 02:24:50.010656834,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-08 01:15:46.747334480,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-07 04:26:48.896189451,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-07 04:26:51.699409246,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 00:17:31.002094030,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-22 04:32:16.475910187,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 16:54:19.592477798,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-27 02:24:50.010656834,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-08 01:15:46.747334480,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-07 04:26:48.896189451,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-07 04:26:51.699409246,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 00:17:31.002094030,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-22 04:32:16.475910187,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-19 16:54:19.592477798,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-05-27 02:24:50.010656834,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-08 01:15:46.747334480,0.7
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-07 04:26:48.896189451,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-07 04:26:51.699409246,0.85
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 00:17:31.002094030,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-22 04:32:16.475910187,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-02 21:24:36.485550642,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 21:07:25.376384020,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-02 21:24:36.485550642,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 21:07:25.376384020,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-02 21:24:36.485550642,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 21:07:25.376384020,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-08 22:02:50.897729635,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-08 22:02:50.897729635,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-08 22:02:50.897729635,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-08 22:02:50.897729635,0.96
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-19 14:57:49.279794693,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-19 14:57:49.279794693,0.66
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-20 10:31:48.025873423,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-20 10:32:10.308995485,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-20 10:31:48.025873423,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-20 10:32:10.308995485,0.81
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-27 04:59:00.972545624,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-04 12:23:53.884383917,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-10 15:27:28.757414579,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-27 04:59:00.972545624,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-04 12:23:53.884383917,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-10 15:27:28.757414579,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-27 07:52:42.179370403,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-27 07:52:42.179370403,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-27 07:52:42.179370403,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-27 07:52:42.179370403,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-27 07:52:42.179370403,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-27 08:50:08.439916134,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-26 08:10:15.641885757,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-27 08:50:08.439916134,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-26 08:10:15.641885757,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-27 08:50:08.439916134,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-26 08:10:15.641885757,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-28 14:15:34.345605612,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-18 11:50:50.244740248,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-28 14:15:34.345605612,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-18 11:50:50.244740248,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-28 14:15:34.345605612,0.88
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-18 11:50:50.244740248,0.98
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-30 15:50:46.380735159,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-01 15:27:27.188207150,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:04:59.553881168,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-30 15:50:46.380735159,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-01 15:27:27.188207150,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:04:59.553881168,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-30 15:50:46.380735159,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-01 15:27:27.188207150,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:04:59.553881168,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-30 15:50:46.380735159,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-01 15:27:27.188207150,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:04:59.553881168,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-06-30 15:50:46.380735159,0.72
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-01 15:27:27.188207150,0.8
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:04:59.553881168,0.83
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 22:25:10.565251589,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 22:25:13.967055082,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 22:25:10.565251589,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-03 22:25:13.967055082,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-12 04:57:32.741071463,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-12 04:57:32.741071463,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-12 04:57:32.741071463,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-31 12:20:35.831116199,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-31 12:20:38.900233746,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-31 12:20:46.475063801,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-31 12:20:56.419157743,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-31 12:20:35.831116199,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-31 12:20:38.900233746,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-31 12:20:46.475063801,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-07-31 12:20:56.419157743,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 05:39:13.658579111,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 05:39:13.658579111,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 05:39:13.658579111,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 05:39:13.658579111,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-09 05:39:13.658579111,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 11:35:07.106087208,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 11:35:07.106087208,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 11:35:07.106087208,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 11:56:12.482364893,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 11:56:49.991220474,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 11:56:53.336269140,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 11:56:12.482364893,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 11:56:49.991220474,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 11:56:53.336269140,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 11:56:12.482364893,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 11:56:49.991220474,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 11:56:53.336269140,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 11:56:12.482364893,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 11:56:49.991220474,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 11:56:53.336269140,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 11:56:12.482364893,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 11:56:49.991220474,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 11:56:53.336269140,0.93
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 14:41:36.057325840,0.34
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 14:41:41.042981625,0.53
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 14:41:59.118874073,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 14:41:36.057325840,0.34
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 14:41:41.042981625,0.53
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 14:41:59.118874073,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 14:41:36.057325840,0.34
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 14:41:41.042981625,0.53
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 14:41:59.118874073,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 14:41:36.057325840,0.34
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 14:41:41.042981625,0.53
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 14:41:59.118874073,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 14:41:36.057325840,0.34
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 14:41:41.042981625,0.53
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 14:41:59.118874073,0.65
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 15:00:24.176785946,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-10 15:00:24.176785946,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-11 22:23:25.664693356,0.56
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-11 22:23:25.664693356,0.56
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-12 08:49:05.223532438,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-12 08:49:05.223532438,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-12 08:49:05.223532438,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-12 08:49:05.223532438,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-12 08:49:05.223532438,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-15 14:33:44.304734945,0.73
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-29 08:01:14.213313818,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-15 14:33:44.304734945,0.73
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-29 08:01:14.213313818,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-15 14:33:44.304734945,0.73
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-29 08:01:14.213313818,0.9
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-19 16:55:45.033824921,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-19 16:55:45.033824921,0.97
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-21 09:21:33.133280038,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-21 09:21:33.133280038,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-21 09:21:33.133280038,0.94
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-22 03:36:19.570010662,0.68
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-22 03:36:19.570010662,0.68
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-22 03:36:19.570010662,0.68
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-28 00:32:43.699687719,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-28 00:32:43.699687719,0.95
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:48:37.889627934,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:48:37.889627934,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:48:37.889627934,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:48:37.889627934,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-30 21:48:37.889627934,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 15:11:15.759520531,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 15:11:15.759520531,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 15:11:15.759520531,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 15:11:15.759520531,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 15:11:15.759520531,0.99
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 20:48:19.291814566,0.69
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 20:48:19.291814566,0.69
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 20:48:19.291814566,0.69
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 20:48:19.291814566,0.69
3895,"Will remdesivir be administered to at least 50,000 patients with SARS-CoV-2 infections in the US, UK, EU member states, and Japan, by the end of 2020?",2020-03-25 00:00:00+01:00,2020-09-01 00:00:00+02:00,1.0,3895,2020-08-31 20:48:19.291814566,0.69
